These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases. Levkau B Basic Res Cardiol; 2008 Mar; 103(2):79-81. PubMed ID: 18324362 [No Abstract] [Full Text] [Related]
6. 18F-FDG positron emission tomography/computed tomography and the "underground map" appearance in imaging Horton's arteritis. Abdul Jalil N; Abdul Rahim N; Md Shalleh N; Rossetti C Singapore Med J; 2008 Jul; 49(7):e178-82. PubMed ID: 18695852 [TBL] [Abstract][Full Text] [Related]
7. [18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain. Yanamoto K; Kumata K; Yamasaki T; Odawara C; Kawamura K; Yui J; Hatori A; Suzuki K; Zhang MR Bioorg Med Chem Lett; 2009 Mar; 19(6):1707-10. PubMed ID: 19217778 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and binding affinities of potential positron emission tomography (PET) ligands with optimal lipophilicity for brain imaging of the dopamine D3 receptor. Part II. Leopoldo M; Lacivita E; De Giorgio P; Contino M; Berardi F; Perrone R Bioorg Med Chem; 2009 Jan; 17(2):758-66. PubMed ID: 19081257 [TBL] [Abstract][Full Text] [Related]